1 Scope of the Report

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Therapeutic Nuclear Drug Market Size 2016-2026

2.1.2 Therapeutic Nuclear Drug Market Size CAGR by Region 2020 VS 2021 VS 2026

2.2 Therapeutic Nuclear Drug Segment by Type

2.2.1 Radium-223

2.2.2 Radium-223

2.2.3 Iodine-131

2.2.4 Other

2.3 Therapeutic Nuclear Drug Market Size by Type

2.3.1 Global Therapeutic Nuclear Drug Market Size CAGR by Type

2.3.2 Global Therapeutic Nuclear Drug Market Size Market Share by Type (2016-2021)

2.4 Therapeutic Nuclear Drug Segment by Application

2.4.1 Thyroid

2.4.2 Bone Metastasis

2.4.3 Lymphoma

2.4.4 Other

2.5 Therapeutic Nuclear Drug Market Size by Application

2.5.1 Global Therapeutic Nuclear Drug Market Size CAGR by Application

2.5.2 Global Therapeutic Nuclear Drug Market Size Market Share by Application (2016-2021)

3 Therapeutic Nuclear Drug Market Size by Players

3.1 Therapeutic Nuclear Drug Market Size Market Share by Players

3.1.1 Global Therapeutic Nuclear Drug Revenue by Players (2019-2021E)

3.1.2 Global Therapeutic Nuclear Drug Revenue Market Share by Players (2019-2021E)

3.2 Global Therapeutic Nuclear Drug Key Players Head office and Products Offered

3.3 Market Concentration Rate Analysis

3.3.1 Competition Landscape Analysis

3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2019-2021E)

3.4 New Products and Potential Entrants

3.5 Mergers & Acquisitions, Expansion

4 Therapeutic Nuclear Drug by Regions

4.1 Therapeutic Nuclear Drug Market Size by Regions (2016-2021)

4.2 Americas Therapeutic Nuclear Drug Market Size Growth (2016-2021)

4.3 APAC Therapeutic Nuclear Drug Market Size Growth (2016-2021)

4.4 Europe Therapeutic Nuclear Drug Market Size Growth (2016-2021)

4.5 Middle East & Africa Therapeutic Nuclear Drug Market Size Growth (2016-2021)

5 Americas

5.1 Americas Therapeutic Nuclear Drug Market Size by Country (2016-2021)

5.2 Americas Therapeutic Nuclear Drug Market Size by Type (2016-2021)

5.3 Americas Therapeutic Nuclear Drug Market Size by Application (2016-2021)

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Therapeutic Nuclear Drug Market Size by Region (2016-2021)

6.2 APAC Therapeutic Nuclear Drug Market Size by Type (2016-2021)

6.3 APAC Therapeutic Nuclear Drug Market Size by Application (2016-2021)

6.4 China

6.5 Japan

6.6 Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

7 Europe

7.1 Europe Therapeutic Nuclear Drug by Country (2016-2021)

7.2 Europe Therapeutic Nuclear Drug Market Size by Type (2016-2021)

7.3 Europe Therapeutic Nuclear Drug Market Size by Application (2016-2021)

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Therapeutic Nuclear Drug by Region (2016-2021)

8.2 Middle East & Africa Therapeutic Nuclear Drug Market Size by Type (2016-2021)

8.3 Middle East & Africa Therapeutic Nuclear Drug Market Size by Application (2016-2021)

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers and Impact

9.1.1 Growing Demand from Key Regions

9.1.2 Growing Demand from Key Applications and Potential Industries

9.2 Market Challenges and Impact

9.3 Market Trends

10 Global Therapeutic Nuclear Drug Market Forecast

10.1 Global Therapeutic Nuclear Drug Forecast by Regions (2021-2026)

10.1.1 Global Therapeutic Nuclear Drug Forecast by Regions (2021-2026)

10.1.2 Americas Therapeutic Nuclear Drug Forecast

10.1.3 APAC Therapeutic Nuclear Drug Forecast

10.1.4 Europe Therapeutic Nuclear Drug Forecast

10.1.5 Middle East & Africa Therapeutic Nuclear Drug Forecast

10.2 Americas Therapeutic Nuclear Drug Forecast by Countries (2021-2026)

10.2.1 United States Therapeutic Nuclear Drug Market Forecast

10.2.2 Canada Therapeutic Nuclear Drug Market Forecast

10.2.3 Mexico Therapeutic Nuclear Drug Market Forecast

10.2.4 Brazil Therapeutic Nuclear Drug Market Forecast

10.3 APAC Therapeutic Nuclear Drug Forecast by Region (2021-2026)

10.3.1 China Therapeutic Nuclear Drug Market Forecast

10.3.2 Japan Therapeutic Nuclear Drug Market Forecast

10.3.3 Korea Therapeutic Nuclear Drug Market Forecast

10.3.4 Southeast Asia Therapeutic Nuclear Drug Market Forecast

10.3.5 India Therapeutic Nuclear Drug Market Forecast

10.3.6 Australia Therapeutic Nuclear Drug Market Forecast

10.4 Europe Therapeutic Nuclear Drug Forecast by Country (2021-2026)

10.4.1 Germany Therapeutic Nuclear Drug Market Forecast

10.4.2 France Therapeutic Nuclear Drug Market Forecast

10.4.3 UK Therapeutic Nuclear Drug Market Forecast

10.4.4 Italy Therapeutic Nuclear Drug Market Forecast

10.4.5 Russia Therapeutic Nuclear Drug Market Forecast

10.5 Middle East & Africa Therapeutic Nuclear Drug Forecast by Region (2021-2026)

10.5.1 Egypt Therapeutic Nuclear Drug Market Forecast

10.5.2 South Africa Therapeutic Nuclear Drug Market Forecast

10.5.3 Israel Therapeutic Nuclear Drug Market Forecast

10.5.4 Turkey Therapeutic Nuclear Drug Market Forecast

10.5.5 GCC Countries Therapeutic Nuclear Drug Market Forecast

10.6 Global Therapeutic Nuclear Drug Forecast by Type (2021-2026)

10.8 Global Therapeutic Nuclear Drug Forecast by Application (2021-2026)

11 Key Players Analysis

11.1 Bayer

11.1.1 Bayer Company Information

11.1.2 Bayer Therapeutic Nuclear Drug Product Offered

11.1.3 Bayer Therapeutic Nuclear Drug Revenue, Gross Margin and Market Share (2019-2021)

11.1.4 Bayer Main Business Overview

11.1.5 Bayer Latest Developments

11.2 Novartis

11.2.1 Novartis Company Information

11.2.2 Novartis Therapeutic Nuclear Drug Product Offered

11.2.3 Novartis Therapeutic Nuclear Drug Revenue, Gross Margin and Market Share (2019-2021)

11.2.4 Novartis Main Business Overview

11.2.5 Novartis Latest Developments

11.3 China Isotope & Radiation

11.3.1 China Isotope & Radiation Company Information

11.3.2 China Isotope & Radiation Therapeutic Nuclear Drug Product Offered

11.3.3 China Isotope & Radiation Therapeutic Nuclear Drug Revenue, Gross Margin and Market Share (2019-2021)

11.3.4 China Isotope & Radiation Main Business Overview

11.3.5 China Isotope & Radiation Latest Developments

11.4 Dongcheng

11.4.1 Dongcheng Company Information

11.4.2 Dongcheng Therapeutic Nuclear Drug Product Offered

11.4.3 Dongcheng Therapeutic Nuclear Drug Revenue, Gross Margin and Market Share (2019-2021)

11.4.4 Dongcheng Main Business Overview

11.4.5 Dongcheng Latest Developments

11.5 Q BioMed

11.5.1 Q BioMed Company Information

11.5.2 Q BioMed Therapeutic Nuclear Drug Product Offered

11.5.3 Q BioMed Therapeutic Nuclear Drug Revenue, Gross Margin and Market Share (2019-2021)

11.5.4 Q BioMed Main Business Overview

11.5.5 Q BioMed Latest Developments

11.6 Curium Pharmaceuticals

11.6.1 Curium Pharmaceuticals Company Information

11.6.2 Curium Pharmaceuticals Therapeutic Nuclear Drug Product Offered

11.6.3 Curium Pharmaceuticals Therapeutic Nuclear Drug Revenue, Gross Margin and Market Share (2019-2021)

11.6.4 Curium Pharmaceuticals Main Business Overview

11.6.5 Curium Pharmaceuticals Latest Developments

11.7 Jubilant DraxImage

11.7.1 Jubilant DraxImage Company Information

11.7.2 Jubilant DraxImage Therapeutic Nuclear Drug Product Offered

11.7.3 Jubilant DraxImage Therapeutic Nuclear Drug Revenue, Gross Margin and Market Share (2019-2021)

11.7.4 Jubilant DraxImage Main Business Overview

11.7.5 Jubilant DraxImage Latest Developments

11.8 Lantheus

11.8.1 Lantheus Company Information

11.8.2 Lantheus Therapeutic Nuclear Drug Product Offered

11.8.3 Lantheus Therapeutic Nuclear Drug Revenue, Gross Margin and Market Share (2019-2021)

11.8.4 Lantheus Main Business Overview

11.8.5 Lantheus Latest Developments

11.9 Spectrum Pharmaceuticals

11.9.1 Spectrum Pharmaceuticals Company Information

11.9.2 Spectrum Pharmaceuticals Therapeutic Nuclear Drug Product Offered

11.9.3 Spectrum Pharmaceuticals Therapeutic Nuclear Drug Revenue, Gross Margin and Market Share (2019-2021)

11.9.4 Spectrum Pharmaceuticals Main Business Overview

11.9.5 Spectrum Pharmaceuticals Latest Developments

11.10 Progenics Pharmaceuticals

11.10.1 Progenics Pharmaceuticals Company Information

11.10.2 Progenics Pharmaceuticals Therapeutic Nuclear Drug Product Offered

11.10.3 Progenics Pharmaceuticals Therapeutic Nuclear Drug Revenue, Gross Margin and Market Share (2019-2021)

11.10.4 Progenics Pharmaceuticals Main Business Overview

11.10.5 Progenics Pharmaceuticals Latest Developments

11. International Isotopes

11.11.1 International Isotopes Company Information

11.11.2 International Isotopes Therapeutic Nuclear Drug Product Offered

11.11.3 International Isotopes Therapeutic Nuclear Drug Revenue, Gross Margin and Market Share (2019-2021)

11.11.4 International Isotopes Main Business Overview

11.11.5 International Isotopes Latest Developments

12 Research Findings and Conclusion

List of Tables

Table 1. Therapeutic Nuclear Drug Market Size CAGR by Region (2020-2026) & ($ Millions)

Table 2. Major Players of Radium-223

Table 3. Major Players of Lutetium-177

Table 4. Major Players of Iodine-131

Table 5. Major Players of Other

Table 6. Therapeutic Nuclear Drug Market Size CAGR by Type (2020-2026) & ($ Millions)

Table 7. Global Therapeutic Nuclear Drug Market Size by Type (2016-2021) & ($ Millions)

Table 8. Global Therapeutic Nuclear Drug Market Size Market Share by Type (2016-2021)

Table 9. Therapeutic Nuclear Drug Market Size CAGR by Application (2016-2021) & ($ Millions)

Table 10. Global Therapeutic Nuclear Drug Market Size by Application (2016-2021) & ($ Millions)

Table 11. Global Therapeutic Nuclear Drug Market Size Market Share by Application (2016-2021)

Table 12. Global Therapeutic Nuclear Drug Revenue by Players (2019-2021E) & ($ Millions)

Table 13. Global Therapeutic Nuclear Drug Revenue Market Share by Players (2019-2021E)

Table 14. Therapeutic Nuclear Drug Key Players Head office and Products Offered

Table 15. Therapeutic Nuclear Drug Concentration Ratio (CR3, CR5 and CR10) & (2019-2021E)

Table 16. New Products and Potential Entrants

Table 17. Mergers & Acquisitions, Expansion

Table 18. Global Therapeutic Nuclear Drug Market Size by Regions 2016-2021 & ($ Millions)

Table 19. Global Therapeutic Nuclear Drug Market Size Market Share by Regions 2016-2021

Table 20. Americas Therapeutic Nuclear Drug Market Size by Country (2016-2021) & ($ Millions)

Table 21. Americas Therapeutic Nuclear Drug Market Size Market Share by Country (2016-2021)

Table 22. Americas Therapeutic Nuclear Drug Market Size by Type (2016-2021) & ($ Millions)

Table 23. Americas Therapeutic Nuclear Drug Market Size Market Share by Type (2016-2021)

Table 24. Americas Therapeutic Nuclear Drug Market Size by Application (2016-2021) & ($ Millions)

Table 25. Americas Therapeutic Nuclear Drug Market Size Market Share by Application (2016-2021)

Table 26. APAC Therapeutic Nuclear Drug Market Size by Region (2016-2021) & ($ Millions)

Table 27. APAC Therapeutic Nuclear Drug Market Size Market Share by Region (2016-2021)

Table 28. APAC Therapeutic Nuclear Drug Market Size by Type (2016-2021) & ($ Millions)

Table 29. APAC Therapeutic Nuclear Drug Market Size Market Share by Type (2016-2021)

Table 30. APAC Therapeutic Nuclear Drug Market Size by Application (2016-2021) & ($ Millions)

Table 31. APAC Therapeutic Nuclear Drug Market Size Market Share by Application (2016-2021)

Table 32. Europe Therapeutic Nuclear Drug Market Size by Country (2016-2021) & ($ Millions)

Table 33. Europe Therapeutic Nuclear Drug Market Size Market Share by Country (2016-2021)

Table 34. Europe Therapeutic Nuclear Drug Market Size by Type (2016-2021) & ($ Millions)

Table 35. Europe Therapeutic Nuclear Drug Market Size Market Share by Type (2016-2021)

Table 36. Europe Therapeutic Nuclear Drug Market Size by Application (2016-2021) & ($ Millions)

Table 37. Europe Therapeutic Nuclear Drug Market Size Market Share by Application (2016-2021)

Table 38. Middle East & Africa Therapeutic Nuclear Drug Market Size by Region (2016-2021) & ($ Millions)

Table 39. Middle East & Africa Therapeutic Nuclear Drug Market Size Market Share by Region (2016-2021)

Table 40. Middle East & Africa Therapeutic Nuclear Drug Market Size by Type (2016-2021) & ($ Millions)

Table 41. Middle East & Africa Therapeutic Nuclear Drug Market Size Market Share by Type (2016-2021)

Table 42. Middle East & Africa Therapeutic Nuclear Drug Market Size by Application (2016-2021) & ($ Millions)

Table 43. Middle East & Africa Therapeutic Nuclear Drug Market Size Market Share by Application (2016-2021)

Table 44. Key and Potential Regions of Therapeutic Nuclear Drug

Table 45. Key Application and Potential Industries of Therapeutic Nuclear Drug

Table 46. Key Challenges of Therapeutic Nuclear Drug

Table 47. Key Trends of Therapeutic Nuclear Drug

Table 48. Global Therapeutic Nuclear Drug Market Size Forecast by Regions (2021-2026) & ($ Millions)

Table 49. Global Therapeutic Nuclear Drug Market Size Market Share Forecast by Regions (2021-2026)

Table 50. Global Therapeutic Nuclear Drug Market Size Forecast by Type (2021-2026) & ($ Millions)

Table 51. Global Therapeutic Nuclear Drug Market Size Market Share Forecast by Type (2021-2026)

Table 52. Global Therapeutic Nuclear Drug Market Size Forecast by Application (2021-2026) & ($ Millions)

Table 53. Global Therapeutic Nuclear Drug Market Size Market Share Forecast by Application (2021-2026)

Table 54. Bayer Details, Company Type, Therapeutic Nuclear Drug Area Served and Its Competitors

Table 55. Bayer Therapeutic Nuclear Drug Product Offered

Table 56. Bayer Therapeutic Nuclear Drug Revenue ($ million), Gross Margin and Market Share (2019-2021E)

Table 57. Bayer Main Business

Table 58. Bayer Latest Developments

Table 59. Novartis Details, Company Type, Therapeutic Nuclear Drug Area Served and Its Competitors

Table 60. Novartis Therapeutic Nuclear Drug Product Offered

Table 61. Novartis Main Business

Table 62. Novartis Therapeutic Nuclear Drug Revenue ($ million), Gross Margin and Market Share (2019-2021E)

Table 63. Novartis Latest Developments

Table 64. China Isotope & Radiation Details, Company Type, Therapeutic Nuclear Drug Area Served and Its Competitors

Table 65. China Isotope & Radiation Therapeutic Nuclear Drug Product Offered

Table 66. China Isotope & Radiation Main Business

Table 67. China Isotope & Radiation Therapeutic Nuclear Drug Revenue ($ million), Gross Margin and Market Share (2019-2021E)

Table 68. China Isotope & Radiation Latest Developments

Table 69. Dongcheng Details, Company Type, Therapeutic Nuclear Drug Area Served and Its Competitors

Table 70. Dongcheng Therapeutic Nuclear Drug Product Offered

Table 71. Dongcheng Main Business

Table 72. Dongcheng Therapeutic Nuclear Drug Revenue ($ million), Gross Margin and Market Share (2019-2021E)

Table 73. Dongcheng Latest Developments

Table 74. Q BioMed Details, Company Type, Therapeutic Nuclear Drug Area Served and Its Competitors

Table 75. Q BioMed Therapeutic Nuclear Drug Product Offered

Table 76. Q BioMed Main Business

Table 77. Q BioMed Therapeutic Nuclear Drug Revenue ($ million), Gross Margin and Market Share (2019-2021E)

Table 78. Q BioMed Latest Developments

Table 79. Curium Pharmaceuticals Details, Company Type, Therapeutic Nuclear Drug Area Served and Its Competitors

Table 80. Curium Pharmaceuticals Therapeutic Nuclear Drug Product Offered

Table 81. Curium Pharmaceuticals Main Business

Table 82. Curium Pharmaceuticals Therapeutic Nuclear Drug Revenue ($ million), Gross Margin and Market Share (2019-2021E)

Table 83. Curium Pharmaceuticals Latest Developments

Table 84. Jubilant DraxImage Details, Company Type, Therapeutic Nuclear Drug Area Served and Its Competitors

Table 85. Jubilant DraxImage Therapeutic Nuclear Drug Product Offered

Table 86. Jubilant DraxImage Main Business

Table 87. Jubilant DraxImage Therapeutic Nuclear Drug Revenue ($ million), Gross Margin and Market Share (2019-2021E)

Table 88. Jubilant DraxImage Latest Developments

Table 89. Lantheus Details, Company Type, Therapeutic Nuclear Drug Area Served and Its Competitors

Table 90. Lantheus Therapeutic Nuclear Drug Product Offered

Table 91. Lantheus Main Business

Table 92. Lantheus Therapeutic Nuclear Drug Revenue ($ million), Gross Margin and Market Share (2019-2021E)

Table 93. Lantheus Latest Developments

Table 94. Spectrum Pharmaceuticals Details, Company Type, Therapeutic Nuclear Drug Area Served and Its Competitors

Table 95. Spectrum Pharmaceuticals Therapeutic Nuclear Drug Product Offered

Table 96. Spectrum Pharmaceuticals Main Business

Table 97. Spectrum Pharmaceuticals Therapeutic Nuclear Drug Revenue ($ million), Gross Margin and Market Share (2019-2021E)

Table 98. Spectrum Pharmaceuticals Latest Developments

Table 99. Progenics Pharmaceuticals Details, Company Type, Therapeutic Nuclear Drug Area Served and Its Competitors

Table 100. Progenics Pharmaceuticals Therapeutic Nuclear Drug Product Offered

Table 101. Progenics Pharmaceuticals Main Business

Table 102. Progenics Pharmaceuticals Therapeutic Nuclear Drug Revenue ($ million), Gross Margin and Market Share (2019-2021E)

Table 103. Progenics Pharmaceuticals Latest Developments

Table 104. International Isotopes Details, Company Type, Therapeutic Nuclear Drug Area Served and Its Competitors

Table 105. International Isotopes Therapeutic Nuclear Drug Product Offered

Table 106. International Isotopes Therapeutic Nuclear Drug Revenue ($ million), Gross Margin and Market Share (2019-2021E)

Table 107. International Isotopes Main Business

Table 108. International Isotopes Latest Developments

List of Figures

Figure 1. Therapeutic Nuclear Drug Report Years Considered

Figure 2. Research Objectives

Figure 3. Research Methodology

Figure 4. Research Process and Data Source

Figure 5. Global Therapeutic Nuclear Drug Market Size Growth Rate 2016-2026 ($ Millions)

Figure 6. Global Therapeutic Nuclear Drug Market Size Market Share by Type in 2020

Figure 7. Therapeutic Nuclear Drug in Thyroid

Figure 8. Global Therapeutic Nuclear Drug Market: Thyroid (2016-2021) & ($ Millions)

Figure 9. Therapeutic Nuclear Drug in Bone Metastasis

Figure 10. Global Therapeutic Nuclear Drug Market: Bone Metastasis (2016-2021) & ($ Millions)

Figure 11. Therapeutic Nuclear Drug in Lymphoma

Figure 12. Global Therapeutic Nuclear Drug Market: Lymphoma (2016-2021) & ($ Millions)

Figure 13. Therapeutic Nuclear Drug in Other

Figure 14. Global Therapeutic Nuclear Drug Market: Other (2016-2021) & ($ Millions)

Figure 15. Global Therapeutic Nuclear Drug Market Size Market Share by Application in 2020

Figure 16. Global Therapeutic Nuclear Drug Revenue Market Share by Player in 2020

Figure 17. Global Therapeutic Nuclear Drug Market Size Market Share by Regions (2016-2021)

Figure 18. Americas Therapeutic Nuclear Drug Market Size 2016-2021 ($ Millions)

Figure 19. APAC Therapeutic Nuclear Drug Market Size 2016-2021 ($ Millions)

Figure 20. Europe Therapeutic Nuclear Drug Market Size 2016-2021 ($ Millions)

Figure 21. Middle East & Africa Therapeutic Nuclear Drug Market Size 2016-2021 ($ Millions)

Figure 22. Americas Therapeutic Nuclear Drug Market Size Market Share by Country in 2020

Figure 23. Americas Therapeutic Nuclear Drug Market Size Market Share by Type in 2020

Figure 24. Americas Therapeutic Nuclear Drug Market Size Market Share by Application in 2020

Figure 25. United States Therapeutic Nuclear Drug Market Size Growth 2016-2021 ($ Millions)

Figure 26. Canada Therapeutic Nuclear Drug Market Size Growth 2016-2021 ($ Millions)

Figure 27. Mexico Therapeutic Nuclear Drug Market Size Growth 2016-2021 ($ Millions)

Figure 28. APAC Therapeutic Nuclear Drug Market Size Market Share by Regions in 2020

Figure 29. APAC Therapeutic Nuclear Drug Market Size Market Share by Type in 2020

Figure 30. APAC Therapeutic Nuclear Drug Market Size Market Share by Application in 2020

Figure 31. China Therapeutic Nuclear Drug Market Size Growth 2016-2021 ($ Millions)

Figure 32. Japan Therapeutic Nuclear Drug Market Size Growth 2016-2021 ($ Millions)

Figure 33. Korea Therapeutic Nuclear Drug Market Size Growth 2016-2021 ($ Millions)

Figure 34. Southeast Asia Therapeutic Nuclear Drug Market Size Growth 2016-2021 ($ Millions)

Figure 35. India Therapeutic Nuclear Drug Market Size Growth 2016-2021 ($ Millions)

Figure 36. Australia Therapeutic Nuclear Drug Market Size Growth 2016-2021 ($ Millions)

Figure 37. Europe Therapeutic Nuclear Drug Market Size Market Share by Country in 2020

Figure 38. Europe Therapeutic Nuclear Drug Market Size Market Share by Type in 2020

Figure 39. Europe Therapeutic Nuclear Drug Market Size Market Share by Application in 2020

Figure 40. Germany Therapeutic Nuclear Drug Market Size Growth 2016-2021 ($ Millions)

Figure 41. France Therapeutic Nuclear Drug Market Size Growth 2016-2021 ($ Millions)

Figure 42. UK Therapeutic Nuclear Drug Market Size Growth 2016-2021 ($ Millions)

Figure 43. Italy Therapeutic Nuclear Drug Market Size Growth 2016-2021 ($ Millions)

Figure 44. Russia Therapeutic Nuclear Drug Market Size Growth 2016-2021 ($ Millions)

Figure 45. Middle East & Africa Therapeutic Nuclear Drug Market Size Market Share by Region in 2020

Figure 46. Middle East & Africa Therapeutic Nuclear Drug Market Size Market Share by Type in 2020

Figure 47. Middle East & Africa Therapeutic Nuclear Drug Market Size Market Share by Application in 2020

Figure 48. Egypt Therapeutic Nuclear Drug Market Size Growth 2016-2021 ($ Millions)

Figure 49. South Africa Therapeutic Nuclear Drug Market Size Growth 2016-2021 ($ Millions)

Figure 50. Israel Therapeutic Nuclear Drug Market Size Growth 2016-2021 ($ Millions)

Figure 51. Turkey Therapeutic Nuclear Drug Market Size Growth 2016-2021 ($ Millions)

Figure 52. GCC Country Therapeutic Nuclear Drug Market Size Growth 2016-2021 ($ Millions)

Figure 53. Americas Therapeutic Nuclear Drug Market Size 2021-2026 ($ Millions)

Figure 54. APAC Therapeutic Nuclear Drug Market Size 2021-2026 ($ Millions)

Figure 55. Europe Therapeutic Nuclear Drug Market Size 2021-2026 ($ Millions)

Figure 56. Middle East & Africa Therapeutic Nuclear Drug Market Size 2021-2026 ($ Millions)

Figure 57. United States Therapeutic Nuclear Drug Market Size 2021-2026 ($ Millions)

Figure 58. Canada Therapeutic Nuclear Drug Market Size 2021-2026 ($ Millions)

Figure 59. Mexico Therapeutic Nuclear Drug Market Size 2021-2026 ($ Millions)

Figure 60. Brazil Therapeutic Nuclear Drug Market Size 2021-2026 ($ Millions)

Figure 61. China Therapeutic Nuclear Drug Market Size 2021-2026 ($ Millions)

Figure 62. Japan Therapeutic Nuclear Drug Market Size 2021-2026 ($ Millions)

Figure 63. Korea Therapeutic Nuclear Drug Market Size 2021-2026 ($ Millions)

Figure 64. Southeast Asia Therapeutic Nuclear Drug Market Size 2021-2026 ($ Millions)

Figure 65. India Therapeutic Nuclear Drug Market Size 2021-2026 ($ Millions)

Figure 66. Australia Therapeutic Nuclear Drug Market Size 2021-2026 ($ Millions)

Figure 67. Germany Therapeutic Nuclear Drug Market Size 2021-2026 ($ Millions)

Figure 68. France Therapeutic Nuclear Drug Market Size 2021-2026 ($ Millions)

Figure 69. UK Therapeutic Nuclear Drug Market Size 2021-2026 ($ Millions)

Figure 70. Italy Therapeutic Nuclear Drug Market Size 2021-2026 ($ Millions)

Figure 71. Russia Therapeutic Nuclear Drug Market Size 2021-2026 ($ Millions)

Figure 72. Spain Therapeutic Nuclear Drug Market Size 2021-2026 ($ Millions)

Figure 73. Egypt Therapeutic Nuclear Drug Market Size 2021-2026 ($ Millions)

Figure 74. South Africa Therapeutic Nuclear Drug Market Size 2021-2026 ($ Millions)

Figure 75. Israel Therapeutic Nuclear Drug Market Size 2021-2026 ($ Millions)

Figure 76. Turkey Therapeutic Nuclear Drug Market Size 2021-2026 ($ Millions)

Figure 77. GCC Country Therapeutic Nuclear Drug Market Size 2021-2026 ($ Millions)